Publications by authors named "Ben Biesterveld"

Article Synopsis
  • Liver transplantation is the main treatment for severe liver diseases and certain cancers, but there is limited information on managing tumors that appear after the transplant.
  • A study of 54 patients who underwent liver surgery after transplantation found that most had hepatocellular carcinoma (HCC) and many did not receive additional therapies before or after surgery.
  • The results indicate that liver resection is generally safe after transplantation, with survival rates comparable to those in patients without a transplant, and should be considered for well-selected patients.
View Article and Find Full Text PDF

Nodular regenerative hyperplasia (NRH) is a primary disease of the liver that may cause noncirrhotic portal hypertension. Common causes include autoimmune, hematologic, immune deficiency, and myeloproliferative disorders. Given the limited data regarding the development of NRH in contemporary immunosuppressive protocols and the occurrence of NRH post-liver transplantation, we systematically reviewed NRH as it pertains to liver transplantation.

View Article and Find Full Text PDF

End-stage kidney disease patients who are referred for transplant undergo an extensive evaluation process to ensure their health prior to transplant due in part to the shortage of available organs. Although management and surveillance guidelines exist for malignancies identified in the transplant and waitlist populations, less is written about the management of premalignant lesions in this population. This review covers the less common premalignant lesions (intraductal papillary mucinous neoplasm, gastrointestinal stromal tumor, thymoma, and pancreatic neuroendocrine tumor) that can be found in the transplant candidate population.

View Article and Find Full Text PDF

Background: Postoperative hemodynamic deterioration among cardiac surgical patients can indicate or lead to adverse outcomes. Whereas prediction models for such events using electronic health records or physiologic waveform data are previously described, their combined value remains incompletely defined. The authors hypothesized that models incorporating electronic health record and processed waveform signal data (electrocardiogram lead II, pulse plethysmography, arterial catheter tracing) would yield improved performance versus either modality alone.

View Article and Find Full Text PDF

Postoperative patients are at risk of life-threatening complications such as hemodynamic decompensation or arrhythmia. Automated detection of patients with such risks via a real-time clinical decision support system may provide opportunities for early and timely interventions that can significantly improve patient outcomes. We utilize multimodal features derived from digital signal processing techniques and tensor formation, as well as the electronic health record (EHR), to create machine learning models that predict the occurrence of several life-threatening complications up to 4 hours prior to the event.

View Article and Find Full Text PDF

Objective: To determine whether trauma patients managed by an admitting or consulting service with a high proportion of physicians exhibiting patterns of unprofessional behaviors are at greater risk of complications or death.

Summary Background Data: Trauma care requires high-functioning interdisciplinary teams where professionalism, particularly modeling respect and communicating effectively, is essential.

Methods: This retrospective cohort study used data from 9 level I trauma centers that participated in a national trauma registry linked with data from a national database of unsolicited patient complaints.

View Article and Find Full Text PDF
Article Synopsis
  • * EV treatment led to significant changes in gene expression, with notable upregulation of genes related to synaptic transmission and downregulation of inflammatory genes, indicating a protective effect on the brain.
  • * The findings suggest that EV therapy can reduce inflammation and promote neurogenesis and neuron survival, highlighting its potential for improving outcomes after TBI and HS.
View Article and Find Full Text PDF

Background: We lack specific treatments for traumatic brain injury (TBI), which remains the leading cause of trauma-related morbidity and mortality. Treatment with valproic acid (VPA) improves outcomes in models of severe TBI with concurrent hemorrhage. However, it is unknown if VPA will have similar benefits after isolated nonlethal TBI, which is the more common clinical scenario.

View Article and Find Full Text PDF
Article Synopsis
  • Trauma is the main cause of death in young individuals, often leading to kidney injury that raises mortality risk; valproic acid (VPA) has shown promise in improving survival in trauma cases.* -
  • Two experimental models on swine demonstrated that VPA significantly improved survival rates and reduced serum creatinine levels, which indicate kidney injury, compared to controls.* -
  • The study concludes that a single dose of VPA (150 mg/kg) effectively protects against acute kidney injury in swine models experiencing severe trauma and blood loss.*
View Article and Find Full Text PDF

Background: Hip fractures are a major cause of morbidity and mortality in the elderly. The American Academy of Orthopedic Surgeons (AAOS) recommends surgical repair within 48 hours of admission, as this is associated with lower postoperative mortality and complications. This study demonstrates the association between patient demographics, level of care, and hospital region to delay in hip fracture repair in the elderly.

View Article and Find Full Text PDF

Objective: Valproic acid (VPA) treatment improves survival in animal models of injuries on doses higher than those allowed by Food and Drug Administration (FDA). We investigated the proteomic alterations induced by a single high-dose (140mg/kg) of VPA (VPA140) compared to the FDA-approved dose of 30mg/kg (VPA30) in healthy humans. We also describe the proteomic and transcriptomic changes induced by VPA140 in an injured patient.

View Article and Find Full Text PDF
Article Synopsis
  • - Traumatic brain injury (TBI) is a serious health issue with no effective cytoprotective treatments, but the drug valproic acid (VPA) shows promise in enhancing recovery following TBI.
  • - In a study using swine, researchers applied TBI and treated the animals with VPA, then analyzed their brain tissue to identify changes in protein expression and biological processes.
  • - The analysis revealed significant alterations in proteins related to injury response and cellular functions, suggesting that VPA may help in the recovery of brain tissue after TBI.
View Article and Find Full Text PDF
Article Synopsis
  • Intraosseous (IO) drug delivery is an alternative to intravenous (IV) access in emergencies, and this study examines how well Valproic Acid (VPA) works when delivered via both methods in a swine model of severe trauma.
  • The results showed similar serum levels of VPA for both IV and IO methods, but only the IO group exhibited significant biological changes in the heart, lung, and liver, with the lung being the most affected.
  • Both the IV and IO groups resulted in 100% survival rates, while the control group had no survivors, indicating that IO-delivered VPA is as effective as IV in life-threatening situations where IV access is not possible.*
View Article and Find Full Text PDF

Patients recovering from cardiovascular surgeries may develop life-threatening complications such as hemodynamic decompensation, making the monitoring of patients for such complications an essential component of postoperative care. However, this need has given rise to an inexorable increase in the number and modalities of data points collected, making it challenging to effectively analyze in real time. While many algorithms exist to assist in monitoring these patients, they often lack accuracy and specificity, leading to alarm fatigue among healthcare practitioners.

View Article and Find Full Text PDF

Background: Trauma and sepsis are individually two of the leading causes of death worldwide. When combined, the mortality is greater than 50%. Thus, it is imperative to have a reproducible and reliable animal model to study the effects of polytrauma and sepsis and test novel treatment options.

View Article and Find Full Text PDF

Background: Hemorrhage is a leading cause of mortality in trauma. Resuscitative endovascular balloon occlusion of the aorta (REBOA) can control hemorrhage, but distal ischemia, subsequent reperfusion injury, and the need for frequent balloon titration remain problems. Improved device design can allow for partial REBOA (pREBOA) that may provide hemorrhage control while also perfusing distally without need for significant provider titration.

View Article and Find Full Text PDF

Background: COVID-19 has mandated rapid adoption of telehealth for surgical care. However, many surgical providers may be unfamiliar with telehealth. This study evaluates the perspectives of surgical providers practicing telehealth care during COVID-19 to help identify targets for surgical telehealth optimization.

View Article and Find Full Text PDF

Background: Traumatic brain injury (TBI) and hemorrhage remain the leading causes of death after trauma. We have previously shown that a dose of valproic acid (VPA) at (150 mg/kg) can decrease brain lesion size and hasten neurologic recovery. The current Food and Drug Administration-approved dose of VPA is 60 mg/kg.

View Article and Find Full Text PDF

Early identification of and response to barriers in telehealth settings will help patients receive optimal care. Here, the authors, based on institutional experience, provide advice on such strategies. This guidance focuses on standardizing expectations, assessing technological knowledge and resource access, evaluating understanding and comfort with telehealth, and assessing social support.

View Article and Find Full Text PDF

Objective: Traumatic brain injury (TBI) is a leading cause of trauma-related morbidity and mortality. Valproic acid (VPA) has been shown to attenuate brain lesion size and swelling within the first few hours following TBI. Because injured neurons are sensitive to metabolic changes, we hypothesized that VPA treatment would alter the metabolic profile in the perilesional brain tissues to create a neuroprotective environment.

View Article and Find Full Text PDF